Unicycive Therapeutics, Inc. (UNCY) DCF Valuation

Unicycive Therapeutics, Inc. (UNCY) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Unicycive Therapeutics, Inc. (UNCY) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Unicycive Therapeutics, Inc.'s (UNCY) financial outlook like an expert! This (UNCY) DCF Calculator comes with pre-populated financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 1.0 .7 .6 .6 .5 .5 .5
Revenue Growth, % 0 0 0 0 -29.02 -7.26 -7.26 -7.26 -7.26 -7.26
EBITDA -.1 .0 -9.0 -18.0 -30.2 .1 .1 .1 .1 .1
EBITDA, % 100 100 100 -1897.48 -4470.81 20 20 20 20 20
Depreciation 2.0 2.0 .0 .0 .3 .4 .4 .4 .3 .3
Depreciation, % 100 100 100 0.73607 42.07 68.56 68.56 68.56 68.56 68.56
EBIT -2.0 -2.0 -9.0 -18.1 -30.5 .1 .1 .1 .1 .1
EBIT, % 100 100 100 -1898.21 -4512.89 20 20 20 20 20
Total Cash .0 .0 16.6 .5 9.7 .6 .5 .5 .4 .4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 0 0
Inventories .0 .0 .0 .0 .0 .4 .3 .3 .3 .3
Inventories, % 100 100 100 0 0 60 60 60 60 60
Accounts Payable .3 .2 .7 .8 .8 .6 .6 .5 .5 .5
Accounts Payable, % 100 100 100 88.96 121.63 97.79 97.79 97.79 97.79 97.79
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 -0.2103 -1.78 -0.39762 -0.39762 -0.39762 -0.39762 -0.39762
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.2 -2.2 -9.5 -18.1 -30.5 .1 .1 .1 .1 .1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .1 -.4 -9.0 -17.9 -30.2 -.4 .5 .5 .4 .4
WACC, % 15.04 15.04 15.04 15.04 15.04 15.04 15.04 15.04 15.04 15.04
PV UFCF
SUM PV UFCF .8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 3
Present Terminal Value 2
Enterprise Value 2
Net Debt -9
Equity Value 11
Diluted Shares Outstanding, MM 25
Equity Value Per Share 0.46

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real UNCY financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly see how your inputs affect Unicycive Therapeutics' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life UNCY Financials: Pre-filled historical and projected data for Unicycive Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Unicycive’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Unicycive’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based UNCY DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Unicycive Therapeutics’ intrinsic value.
  4. Test Scenarios: Explore various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial strategies.

Why Choose This Calculator for Unicycive Therapeutics, Inc. (UNCY)?

  • Accurate Data: Utilizes real Unicycive financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Pre-defined calculations save you the hassle of building from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Designed with an intuitive interface and clear instructions for all users.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive valuation models for analyzing Unicycive Therapeutics, Inc. (UNCY) investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to shape strategic decisions for the company.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in Unicycive Therapeutics, Inc. (UNCY).
  • Students and Educators: Utilize real-world data to enhance learning in financial modeling related to biotech.
  • Biotech Enthusiasts: Gain insights into how companies like Unicycive Therapeutics, Inc. (UNCY) are valued in the healthcare market.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Unicycive Therapeutics, Inc. (UNCY).
  • Real-World Data: Unicycive's historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Unicycive Therapeutics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results regarding Unicycive's financial health.

No products were found matching.